1066P Final results from the ENGOT-Ov41/GEICO 69-O/ANITA randomised phase III trial of atezolizumab (atezo), platinum-based chemotherapy (CT) and maintenance niraparib (nira) for late-relapsing recurrent ovarian cancer (rOC) | Publicación